HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.

AbstractBACKGROUND:
The peritumoral environment has been implicated to be important in the process of metastasis and recurrence in hepatocellular carcinoma (HCC). Our aims were to assess the prognostic value of proline-rich tyrosine kinase 2 (Pyk2) in HCC and investigate related molecular mechanism.
METHODS:
Expression of Pyk2 was tested by immunohistochemistry in tissue microarrays containing 141 paired HCC samples. Correlation between Pyk2 and vascular endothelial growth factor (VEGF) expression in clinical samples was analyzed by Spearman rank correlation. Matrigel invasion, anchorage-independent growth assay and immunoblotting were performed to study the effect of Pyk2 on the invasion and progression of HCC cells and phosphoinositide 3-kinase (PI3K)/AKT pathway activation.
RESULTS:
Higher Pyk2 density in both tumor and peritumor was associated with lower overall survival (P = 0.044; P = 0.041, respectively), serum AFP levels > 1,000 ng/ml (P = 0.013; P = 0.032, respectively) and postoperative distant metastasis (both P < 0.001). However, only higher peritumoral Pyk2 density was related to lower disease-free survival (P = 0.014) and vascular invasion (P = 0.035). A significant correlation between Pyk2 and VEGF density in tumor or peritumoral liver tissue was observed (r = 0. 3133, P = 0.0002; r = 0.5176, P < 0.0001, respectively). Immunoblotting showed that Pyk2 activated PI3K-AKT pathway to upregulate VEGF expression in HL-7702, SMMC-7721 and HepG2 cells.
CONCLUSIONS:
High Pyk2, especially peritumoral Pyk2 was associated with poor survival, disease recurrence, and metastasis in HCC. PI3K-AKT pathway was involved in Pyk2-mediated VEGF expression during HCC progression and invasion.
AuthorsJie Cao, Yao Chen, Jing Fu, You-Wen Qian, Yi-Bin Ren, Bo Su, Tao Luo, Rong-Yang Dai, Liang Huang, Jian-Jun Yan, Meng-Chao Wu, Yi-Qun Yan, Hong-Yang Wang
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 20 Suppl 3 Pg. S312-23 (Dec 2013) ISSN: 1534-4681 [Electronic] United States
PMID22618716 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Phosphatidylinositol 3-Kinase
  • Focal Adhesion Kinase 2
  • Proto-Oncogene Proteins c-akt
Topics
  • Apoptosis
  • Blotting, Western
  • Carcinoma, Hepatocellular (enzymology, mortality, secondary)
  • Cell Adhesion
  • Cell Movement
  • Cell Proliferation
  • Female
  • Focal Adhesion Kinase 2 (metabolism)
  • Follow-Up Studies
  • Gene Expression Regulation, Neoplastic (physiology)
  • Humans
  • Immunoenzyme Techniques
  • Liver (metabolism)
  • Liver Neoplasms (enzymology, mortality, pathology)
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Phosphatidylinositol 3-Kinase (metabolism)
  • Prognosis
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survival Rate
  • Tissue Array Analysis
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: